Symbol       Canada   US  

Company Profile



Dipexium Pharmaceuticals, Inc.
Symbol: NASDAQ : DPRX
Email:
Website: www.dipexium.com
Dipexium Pharmaceuticals, Inc. is a biotechnology company formed to develop and commercialize Locilex™ (pexiganan acetate cream 1%), a novel, broad spectrum, small peptide topical antibiotic for the treatment of certain mild and moderate skin infections in superficial wounds. Initially, Locilex™ is targeted for the treatment of mild infections of diabetic foot ulcers. Based on a compilation of available clinical and microbiology data, Locilex™ is also considered a promising product candidate, to treat acute bacterial skin and skin structure infections (ABSSSI) in superficial wounds, including infected decubitus ulcers, infected burns, infected surgical wounds and nasal colonization of methicillin-resistant staphylococcus aureus (MRSA).
 
DPRX Discussion Forums
Seeking Alpha
Silicon Investor
StockHouse
Yahoo

Live Discussion of DPRX


Search by Symbol       Canada   US  


Top